Benzinga | May 5, 2021 07:20AM EDT

Needham Maintains Buy on Globus Medical, Raises Price Target to $82

Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $75 to $82.